2025
ICD-10-CM
Diagnosis
Code

T80.82 Complication of immune effector cellular therapy

  • Non-billable
  • 2022–2025

T80.82 is a non-billable/non-specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Complication of immune effector cellular therapy.

Inclusion term

  • Complication of chimeric antigen receptor (CAR-T) cell therapy

  • Complication of IEC therapy

Use additional code

  • Code to identify the specific complication, such as:

    • Cytokine release syndrome (D89.83-)

    • Immune effector cell-associated neurotoxicity syndrome (G92.0-)

Type 2 excludes

  • Adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)

  • Complication of bone marrow transplant (T86.0)

  • Complication of stem cell transplant (T86.5)

Codes

Versions

  1. 2025

    Code changed

    • Type 2 excludes

        • complication of bone marrow transplant (T86.0)
        • complication of stem cell transplant (T86.5)
        • adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
        • complication of bone marrow transplant (T86.0)
        • complication of stem cell transplant (T86.5)

  2. 2024

    No changes

  3. 2023

    No changes

  4. 2022

    New code